Delivering a Multi-disease Screening Tool to Migrant Populations

NACompletedINTERVENTIONAL
Enrollment

980

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
HivHepatitis BHepatitis CTuberculosisChagas DiseaseSchistosomiasisStrongyloidiasisFemale Genital Mutilation Type I StatusFemale Genital Mutilation Type II StatusFemale Genital Mutilation Type III Status
Interventions
OTHER

Clinical decision support system for screening of migrants using the ISMiHealth software tool.

"The implementation of the screening programme will be facilitated using a simple and user-friendly software tool (ISMiHealth).~When an individual attends the PCC for any reason, the tool will generate an alert for health professionals in the EPR system, with recommendations on the conditions that should be considered for screening, based on this patient's characteristics (country of birth, age and sex). Health professionals will decide what diseases/conditions should be screened for, supported by the recommendations of the digital software (intervention centres) or based on their knowledge on the epidemiological background of the diseases (control centres). In any case, health professionals will be responsible for requesting serology tests, chest radiographies and/or referrals to specialists."

Trial Locations (2)

Unknown

Servicio Andaluz de Salud (SAS) (administration of the participant PCCs in Andalusia), Almería

Institut Català de la Salut (ICS) (administration of the participant PCCs in Catalonia), Tortosa

All Listed Sponsors
collaborator

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

collaborator

Distrito Sanitario Poniente de Almería

UNKNOWN

collaborator

Hospital de Poniente

UNKNOWN

collaborator

Universidad de Granada

OTHER

collaborator

Consorci d'Atenció Primària de Salut de l'Eixample

OTHER

lead

Barcelona Institute for Global Health

OTHER

NCT05868005 - Delivering a Multi-disease Screening Tool to Migrant Populations | Biotech Hunter | Biotech Hunter